Malaria :: Multiple malaria infection inhibits spread of parasite
People who are frequently infected with malaria parasites can develop immunity against the gametocyte, the infectious stage. This immunity inhibits the spread of the parasite.
People who are frequently infected with malaria parasites can develop immunity against the gametocyte, the infectious stage. This immunity inhibits the spread of the parasite.
Satellite solutions delivering information and communication technologies can help improve health in sub-Saharan Africa; this was the main conclusion of a dedicated telemedicine task force which met recently in Botswana. To make these solutions a reality, some short-term, concrete actions have been suggested in a pilot projects proposal.
A clinical trial conducted by researchers at the Johns Hopkins Bloomberg School of Public concluded that daily zinc supplements reduced the risk of death among children aged 12 to 48 months by 18 percent. However, the researchers did not find any significant reduction in mortality among children 1 to 11 months of age.
A case-control study in two populations in Mali, West Africa has shown that glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with significant protection against severe, life-threatening malaria. Researchers from the US National Institute of Allergy and Infectious Diseases and the University of Bamako, Mali, led by Thomas E. Wellems, report the findings this week in the open access journal PLoS Medicine.
A new study by Christopher Plowe and colleagues (University of Maryland School of Medicine) on a malaria vaccine used at a testing site in Mali calls into question whether the best vaccine was chosen to be tested at this particular site.
An article published in ‘The Lancet’ by researchers from the Menzies School of Health Research (MSHR) in Darwin has revealed a breakthrough in the battle to treat Malaria ? a disease which effects 40 per cent of the worlds population.
According to the World Health Organisation, millions more South Asians will suffer from diseases like malaria and cholera, or go hungry due to global warming, but governments are not fully aware of the dangers.
Inadequate intellectual stimulation and poor nutrition, especially iodine and iron deficiencies, are likely to blame for hindering more than 200 million children in developing countries from meeting their full potential, says a Purdue University researcher.
The Global Fund to Fight AIDS, Tuberculosis and Malaria enthusiastically welcomes Japan?s announcement of a new contribution of US$186 million.
Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) announced that ASAQ, the new fixed-dose combination of artesunate (AS) and amodiaquine (AQ), will soon be available throughout sub-Saharan Africa.